- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- OncNursingNews.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Case-Based Roundtable Meetings Spotlight April 1, 2021
Dorff Discusses the CARD Trial in Metastatic Castrate- Resistant Prostate Cancer
May 07, 2021
Clinical Articles
During a virtual Targeted Oncology Case-Based Roundtable event, Tanya Dorff, MD, discussed the case of a 75-year-old man with metastatic castration-resistant prostate cancer.
Triplet Regimens Show Positive Efficacy for Transplant- Ineligible Multiple Myeloma
May 07, 2021
Clinical Articles
During a Targeted Oncology Case-Based Roundtable event, Rafael Fonseca, MD, discussed the case of a 72-year-old patient with multiple myeloma.
Molecular Testing Leads to Better Results on Olaparib for Patients With mCRPC
May 05, 2021
Clinical Articles
Findings from the PROfound and National Comprehensive Cancer Network guidelines for molecular testing were reviewed for a discussion on treatment for 60-year-old man with metastatic castration-resistant prostate cancer.
Roundtable Discussion: Challenges in Adjuvant Treatment for Patients With NSCLC
May 04, 2021
Clinical Articles
During a Targeted Oncology Case-Based Roundtable event, Ticiana Leal, MD, discussed the case of a patient with non–small cell lung cancer with a group of peers.
Ramucirumab Demonstrates PFS Efficacy in Lung Cancer With EGFR Mutations
May 04, 2021
Clinical Articles
Karen L. Reckamp, discussed the progression-free survival benefit achieved with ramucirumab in patients with EGFR-positive lung cancer.
Roundtable Discussion: Smith Leads a Discussion on the Utility of Genomic Testing in Prostate Cancer
May 03, 2021
Clinical Articles
During a Targeted Oncology Case-Based Roundtable event, Matthew Smith, MD, PhD, discussed genomic testing in prostate cancer with a group of peers.
Data Show That PD-L1 Status Affects the Efficacy of Pembrolizumab in Non–Small Cell Lung Cancer
May 01, 2021
Clinical Articles
Ravi Salgia, MD, PhD, discussed the case of a 59-year-old patient with non–small cell lung cancer during a virtual Targeted Oncology Case-Based Roundtable event.
Brose Explores Treatments for a Patient With RET-Mutated Thyroid Cancer
May 01, 2021
Clinical Articles
During a virtual Targeted Oncology Case-Based Roundtable event, Marcia S. Brose, MD, PhD, discussed the case of a 58-year-old patients with RET-mutated thyroid cancer.
Bordoni Compares Trials in Extensive-Stage Small Cell Lung Cancer
April 30, 2021
Clinical Articles
During a virtual Targeted Oncology Case-Based Roundtable event, Rodolfo Bordoni, MD, discussed recent clinical trials in the extensive-stage small cell lung cancer space.
Alsina Explores Options for Patients With Transplant- Eligible Multiple Myeloma
April 30, 2021
Clinical Articles
Melissa Alsina, MD, reviewed the treatment options for transplant-eligible multiple myeloma based on the case of a 52-year-old male patient.
Ornstein Discusses the Use of Cabozantinib in Clear Cell Renal Cell Carcinoma
April 29, 2021
Clinical Articles
During a virtual Targeted Oncology Case-Based Roundtable event, Moshe Ornstein, MD, MA, discussed the case of a 59-year-old patient with clear cell renal cell carcinoma.
LIBRETTO-001 and ARROW Trials Show Positive Data in RET Fusion–Positive Lung Cancer
April 28, 2021
Clinical Articles
Jessica Bauman, MD, reviewed data from the LIBRETTO-001 and ARROW trials which show the efficacy and safety of selpercatinib and pralsetinib for the treatment of patients with RET fusion-positive lung cancer.
Petrylak Explores the Use of Maintenance Avelumab in Metastatic Bladder Cancer
April 28, 2021
Clinical Articles
During a virtual Targeted Oncology Case-Based Roundtable event, Daniel P. Petrylak, MD, discussed the case of a 66-year-old woman with metastatic bladder cancer.
Cemiplimab Is Effective as Anti–PD-1 Therapy in Cutaneous Squamous Cell Carcincoma
April 26, 2021
Clinical Articles
Ezra Cohen, MD, lead a discussion on the efficacy of cemiplimab-rwlc for the treatment of cutaneous squamous cell carcinoma.
Roundtable Discussion: Treating Radioiodine-Refractory Differentiated Thyroid Cancer
April 26, 2021
Clinical Articles
During a virtual Targeted Oncology Case-Based Roundtable event, Lori Wirth, MD, discussed the treatment patients with radioiodine-refractory differentiated thyroid cancer with a group of peers.